[PR Newswire] - SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today reviewed the platform of data and know-how that supports development of ANX-188 in multiple indications, including ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment